• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性胸膜间皮瘤:全面综述

Malignant pleural mesothelioma: a comprehensive review.

作者信息

Ismail-Khan Roohi, Robinson Lary A, Williams Charles C, Garrett Christopher R, Bepler Gerold, Simon George R

机构信息

Thoracic Oncology Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.

出版信息

Cancer Control. 2006 Oct;13(4):255-63. doi: 10.1177/107327480601300402.

DOI:10.1177/107327480601300402
PMID:17075562
Abstract

BACKGROUND

The incidence of malignant mesothelioma continues to increase, but the disease remains difficult to detect early and treat effectively.

METHODS

The authors review the pathogenesis, incidence, clinical presentation, diagnosis, pathology, and both standard and experimental treatments for mesothelioma.

RESULTS

When possible, surgery (video-assisted thoracoscopy, pleurectomy/decortication, or extrapleural pneumonectomy) is utilized. Effects on underlying structures limit application of radiation therapy, but some systemic agents are beginning to enhance survival.

CONCLUSIONS

The disease is expected to increase in incidence till 2020, so awareness of this entity as a possible diagnosis should be heightened. In patients with advanced disease, several newer antitumor agents are already showing a capability of extending survival so it is not unreasonable to expect further progress in this area.

摘要

背景

恶性间皮瘤的发病率持续上升,但该疾病仍难以早期检测和有效治疗。

方法

作者回顾了间皮瘤的发病机制、发病率、临床表现、诊断、病理学以及标准和实验性治疗方法。

结果

在可能的情况下,采用手术(电视辅助胸腔镜手术、胸膜切除术/去皮质术或胸膜外全肺切除术)。对深层结构的影响限制了放射治疗的应用,但一些全身性药物已开始提高生存率。

结论

预计到2020年该疾病的发病率将上升,因此应提高对这一可能诊断的认识。在晚期疾病患者中,几种新型抗肿瘤药物已显示出延长生存期的能力,因此预计该领域会有进一步进展并非不合理。

相似文献

1
Malignant pleural mesothelioma: a comprehensive review.恶性胸膜间皮瘤:全面综述
Cancer Control. 2006 Oct;13(4):255-63. doi: 10.1177/107327480601300402.
2
Malignant pleural mesothelioma.恶性胸膜间皮瘤
Cancer Treat Res. 2001;105:327-73. doi: 10.1007/978-1-4615-1589-0_13.
3
Diagnosis and treatment of malignant pleural mesothelioma.恶性胸膜间皮瘤的诊断与治疗
Arch Bronconeumol. 2015 Apr;51(4):177-84. doi: 10.1016/j.arbres.2014.06.005. Epub 2014 Jul 22.
4
A case of diffuse pleural mesothelioma in which contralateral exploratory thoracoscopy assisted the selection of therapy.一例弥漫性胸膜间皮瘤,对侧诊断性胸腔镜检查辅助治疗方案的选择。
Ann Thorac Cardiovasc Surg. 2005 Aug;11(4):252-5.
5
Malignant mesothelioma of the pleural space.胸膜腔恶性间皮瘤。
Oncology (Williston Park). 1999 Jul;13(7):919-26; discussion 926, 931-2.
6
[Malignant pleural mesothelioma: diagnosis and treatment].[恶性胸膜间皮瘤:诊断与治疗]
Rev Pneumol Clin. 2013 Feb;69(1):26-35. doi: 10.1016/j.pneumo.2012.12.003. Epub 2013 Jan 14.
7
Malignant pleural mesothelioma.恶性胸膜间皮瘤
Wien Klin Wochenschr. 2016 Sep;128(17-18):609-10. doi: 10.1007/s00508-016-1039-0.
8
Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.恶性胸膜间皮瘤:ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii43-4. doi: 10.1093/annonc/mdn083.
9
Clinical features and current treatment of diffuse malignant pleural mesothelioma.弥漫性恶性胸膜间皮瘤的临床特征与当前治疗方法
Lung Cancer. 1995 Jun;12 Suppl 2:S127-46. doi: 10.1016/s0169-5002(10)80011-x.
10
Pleural mesothelioma.胸膜间皮瘤
Curr Opin Pulm Med. 1999 Jul;5(4):259-68. doi: 10.1097/00063198-199907000-00015.

引用本文的文献

1
Twice as Effective? Pressurized Intra-Thoracic Aerosol Chemotherapy: New Frontiers in Pleural Mesothelioma.效果加倍?胸腔内加压雾化化疗:胸膜间皮瘤的新前沿
Med Sci (Basel). 2025 Jun 2;13(2):72. doi: 10.3390/medsci13020072.
2
Malignant Pleural Mesothelioma: A Comprehensive Review.恶性胸膜间皮瘤:综述
J Clin Med. 2024 Sep 30;13(19):5837. doi: 10.3390/jcm13195837.
3
Systematic Review, Meta-Analysis and Bioinformatic Analysis of Biomarkers for Prognosis of Malignant Pleural Mesothelioma.恶性胸膜间皮瘤预后生物标志物的系统评价、荟萃分析和生物信息学分析
Diagnostics (Basel). 2022 Sep 12;12(9):2210. doi: 10.3390/diagnostics12092210.
4
Define the Two Molecular Subtypes of Epithelioid Malignant Pleural Mesothelioma.定义上皮样恶性胸膜间皮瘤的两个分子亚型。
Cells. 2022 Sep 19;11(18):2924. doi: 10.3390/cells11182924.
5
Evaluation of Detector Position and Light Fluence Distribution Using an Infrared Navigation System during Pleural Photodynamic Therapy.评估胸腔光动力疗法中使用红外导航系统时的探测器位置和光辐射通量分布。
Photochem Photobiol. 2023 Mar;99(2):814-825. doi: 10.1111/php.13697. Epub 2022 Sep 16.
6
Prognostic Bone Metastasis-Associated Immune-Related Genes Regulated by Transcription Factors in Mesothelioma.间皮瘤中由转录因子调控的预后性骨转移相关免疫相关基因。
Biomed Res Int. 2022 Jan 27;2022:9940566. doi: 10.1155/2022/9940566. eCollection 2022.
7
Malignant pleural mesothelioma: an update.恶性胸膜间皮瘤:最新进展。
J Bras Pneumol. 2021 Dec 13;47(6):e20210129. doi: 10.36416/1806-3756/e20210129. eCollection 2021.
8
A Rare Case of Malignant Pleural Mesothelioma in a Young Healthy Male Without Asbestos Exposure.一名无石棉接触史的年轻健康男性患恶性胸膜间皮瘤的罕见病例。
Cureus. 2021 Aug 15;13(8):e17199. doi: 10.7759/cureus.17199. eCollection 2021 Aug.
9
Inhibition of cyclin-dependent kinase 7 down-regulates yes-associated protein expression in mesothelioma cells.抑制周期蛋白依赖性激酶 7 下调间皮瘤细胞中 yes 相关蛋白的表达。
J Cell Mol Med. 2020 Jan;24(1):1087-1098. doi: 10.1111/jcmm.14841. Epub 2019 Nov 21.
10
Building a Bridge between Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma: Investigating the Effect of Chemotherapy on Immune Checkpoint Expression.在恶性胸膜间皮瘤中建立化疗与免疫治疗的桥梁:研究化疗对免疫检查点表达的影响。
Int J Mol Sci. 2019 Aug 26;20(17):4182. doi: 10.3390/ijms20174182.